Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling.
about
Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouseRole of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models.Statement by the Growth Hormone Research Society on the GH/IGF-I axis in extending health span.Dynamic analysis of GH receptor conformational changes by split luciferase complementation.Elevated GH/IGF-I promotes mammary tumors in high-fat, but not low-fat, fed miceInhibitory GH receptor extracellular domain monoclonal antibodies: three-dimensional epitope mappingRemoval of growth hormone receptor (GHR) in muscle of male mice replicates some of the health benefits seen in global GHR-/- mice.TIMP3 Modulates GHR Abundance and GH SensitivityThe contribution of growth hormone to mammary neoplasiaModulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system.Growth hormone excess and the development of growth hormone receptor antagonists.Evaluation of growth hormone (GH) action in mice: discovery of GH receptor antagonists and clinical indications.Pegvisomant: current and potential novel therapeutic applications.Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment.Insulin-like growth factors and insulin: at the crossroad between tumor development and longevity.Role of the growth hormone–IGF-1 axis in cancer
P2860
Q24613998-0BB82099-C87D-492E-95BE-CC425ED98F34Q24645123-77BB8D66-541C-4254-A993-68850C8D3353Q30448722-29287594-60A1-440F-BF66-223343616E2EQ34422493-AFBE45C5-4F2D-4255-AB3F-3C85B8509AD1Q34434910-215AB78D-3534-4E8D-B791-A3B9A2E18DE8Q35590849-8C617ACD-0097-4A28-B174-E3864509C7D5Q35975972-ACC1F118-DC01-4416-83DD-081E2CF5EF3EQ36945222-F16F670E-A6B1-4C9E-A366-B23CD83CDDB2Q37078157-7FE4333A-AC64-4324-BE6F-1816F6069809Q37202220-88BD4DB6-0218-443B-A797-CB7052A31136Q37212629-B1C28ACC-C3F2-4689-8F37-D9F6F0E68240Q37619460-A594C884-5F5E-4A3A-8B7B-CAE11B2708A2Q37633543-EEA336D6-F7AE-4DC3-A7D8-1EC23CB071D5Q37689956-3E3C99E7-AB3E-426C-9300-405F034AAED4Q37994048-D1B19353-BD53-4AD0-B7F9-482AD7CD2F0EQ57252658-614476BF-6E22-4208-B13D-5DAC8A0762A7
P2860
Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Inhibition of estrogen-indepen ...... n of growth hormone signaling.
@en
Inhibition of estrogen-indepen ...... n of growth hormone signaling.
@nl
type
label
Inhibition of estrogen-indepen ...... n of growth hormone signaling.
@en
Inhibition of estrogen-indepen ...... n of growth hormone signaling.
@nl
prefLabel
Inhibition of estrogen-indepen ...... n of growth hormone signaling.
@en
Inhibition of estrogen-indepen ...... n of growth hormone signaling.
@nl
P2093
P356
P1433
P1476
Inhibition of estrogen-indepen ...... n of growth hormone signaling.
@en
P2093
Daniel D Lantvit
Jeffrey E Green
John J Kopchick
Karen T Coschigano
Konstantin T Christov
Rajendra G Mehta
Samad Hedayat
Steven M Swanson
Terry G Unterman
Vera H Ray
P304
P356
10.1093/CARCIN/BGL138
P407
P577
2006-08-17T00:00:00Z